• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 3, Issue 6
  3. Authors

Online ISSN: 2515-8260

Volume3, Issue6

A new horizon for sepsis: Personalised medicine: Hype or hope?

    R.J. McGalliard E.D. Carrol

European Journal of Molecular & Clinical Medicine, 2017, Volume 3, Issue 6, Pages 289-293

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background
Sepsis is a medical emergency and a major public health concern for society. It is estimated that there are 18 million cases of sepsis annually, and in developing countries over 6 million neonates and children die each year[1]. Data from the US supports the fact that the incidence and mortality from sepsis is rising, which reflects a global trend[2–4]. Reasons for this increasing incidence is likely due to a combination of ageing populations with multiple co-morbidities, improved life expectancy from other diseases, rising prevalence of people taking immunosuppressants and escalating antibiotic resistance[5]. Analysis of sepsis in a worldwide audit of intensive care units found that mortality was as high as 30%[6]. Within the UK, sepsis costs the NHS £830 million a year directly and between 36,000-64,0000 deaths. When sensitivity analyses are applied the estimated annual cost of sepsis to the UK is over £10 billion. [7]
Keywords:
    inflammatory effects
  • PDF (884 K)
  • XML
(2017). A new horizon for sepsis: Personalised medicine: Hype or hope?. European Journal of Molecular & Clinical Medicine, 3(6), 289-293.
R.J. McGalliard; E.D. Carrol. "A new horizon for sepsis: Personalised medicine: Hype or hope?". European Journal of Molecular & Clinical Medicine, 3, 6, 2017, 289-293.
(2017). 'A new horizon for sepsis: Personalised medicine: Hype or hope?', European Journal of Molecular & Clinical Medicine, 3(6), pp. 289-293.
A new horizon for sepsis: Personalised medicine: Hype or hope?. European Journal of Molecular & Clinical Medicine, 2017; 3(6): 289-293.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 44
  • PDF Download: 90
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus